Skip to main content
Fig. 2 | Insights into Imaging

Fig. 2

From: Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases

Fig. 2

PET principle: imaging agents used for PET are radioactive probes emitting positively charged anti-electrons (positrons). The positron travels a short distance (1–3 mm) before it annihilates with any electron to give two photons of 511 keV travelling under a mutual angle of 180°. It is this pair of coincident high energy photons that underly the PET principle allowing in vivo quantitative 3D imaging through coincident detection using a gantry of multiple detectors around the patient

Back to article page